Author:
Chen Wenge,Xiao Yingying,Chen Jianzhong,Liu Jian,Shao Jingwei,Li Tao,Zhu Yewei,Ma Ji,Gao Yu,Wang Jichuang,Xu Jianguo,Lu Yusheng,Jia Lee
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Wang, J. et al. Synthesis, spectral characterization, and in vitro cellular activities of metapristone, a potential cancer metastatic chemopreventive agent derived from mifepristone (RU486). The AAPS journal 16, 289–298 (2014).
2. Yu, S. et al. Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention. Scientific reports 6, 22388 (2016).
3. Wang, J. et al. In vitro and in vivo efficacy and safety evaluation of metapristone and mifepristone as cancer metastatic chemopreventive agents. Biomedicine & pharmacotherapy=Biomedecine 78, 291–300 (2016).
4. Gao, Y. et al. The Architecture and Function of Monoclonal Antibody‐Functionalized Mesoporous Silica Nanoparticles Loaded with Mifepristone: Repurposing Abortifacient for Cancer Metastatic Chemoprevention. Small 12, 2595–2608 (2016).
5. Wan, L. et al. Aspirin, lysine, mifepristone and doxycycline combined can effectively and safely prevent and treat cancer metastasis: prevent seeds from gemmating on soil. Oncotarget 6, 35157–35172 (2015).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献